Cancer 0 6 0 6 B-treatment
therapies 7 16 7 16 I-treatment
, 16 17 16 17 O
including 18 27 18 27 O
chemotherapy 28 40 28 40 B-treatment
, 40 41 40 41 O
radiation 42 51 42 51 B-treatment
( 52 53 52 53 O
non 53 56 53 56 O
- 56 57 56 57 O
study 57 62 57 62 O
regimen 63 70 63 70 O
related 71 78 71 78 O
) 78 79 78 79 O
, 79 80 79 80 O
biologics 81 90 81 90 B-treatment
or 91 93 91 93 O
kinase 94 100 94 100 B-treatment
inhibitors 101 111 101 111 I-treatment
, 111 112 111 112 O
G 113 114 113 114 B-treatment
- 114 115 114 115 I-treatment
CSF 115 118 115 118 I-treatment
or 119 121 119 121 O
GM 122 124 122 124 B-treatment
- 124 125 124 125 I-treatment
CSF 125 128 125 128 I-treatment
within 129 135 129 135 O
4 136 137 136 137 B-upper_bound
weeks 138 143 138 143 I-upper_bound
prior 144 149 144 149 I-upper_bound
to 150 152 150 152 O
the 153 156 153 156 O
first 157 162 157 162 O
scheduled 163 172 163 172 O
G100 173 177 173 177 B-treatment
dose 178 182 178 182 O

Central 0 7 183 190 O
nervous 8 15 191 198 O
system 16 22 199 205 O
involvement 23 34 206 217 O
with 35 39 218 222 O
lymphoma 40 48 223 231 B-cancer
, 48 49 231 232 O
including 50 59 233 242 O
parenchymal 60 71 243 254 B-cancer
and 72 75 255 258 O
leptomeningeal 76 90 259 273 B-cancer
disease 91 98 274 281 I-cancer

Concurrent 0 10 282 292 O
, 10 11 292 293 O
recent 12 18 294 300 O
( 19 20 301 302 O
≤ 20 21 302 303 O
4 22 23 304 305 B-upper_bound
weeks 24 29 306 311 I-upper_bound
ago 30 33 312 315 I-upper_bound
) 33 34 315 316 O
or 35 37 317 319 O
anticipated 38 49 320 331 O
treatment 50 59 332 341 B-treatment
with 60 64 342 346 I-treatment
systemic 65 73 347 355 I-treatment
corticosteroids 74 89 356 371 I-treatment
at 90 92 372 374 O
any 93 96 375 378 O
dose 97 101 379 383 O

Creatinine 0 10 384 394 B-clinical_variable
> 11 12 395 396 O
1.5x 13 17 397 401 B-lower_bound
ULN 18 21 402 405 I-lower_bound

During 0 6 406 412 O
Patient 7 14 413 420 O
Expansion 15 24 421 430 O
, 24 25 430 431 O
enrollment 26 36 432 442 O
will 37 41 443 447 O
be 42 44 448 450 O
limited 45 52 451 458 O
to 53 55 459 461 O
relapsed 56 64 462 470 O
or 65 67 471 473 O
refractory 68 78 474 484 O
follicular 79 89 485 495 B-cancer
NHL 90 93 496 499 I-cancer

ECG 0 3 500 503 B-treatment
without 4 11 504 511 O
evidence 12 20 512 520 O
of 21 23 521 523 O
clinically 24 34 524 534 O
significant 35 46 535 546 O
arrhythmia 47 57 547 557 B-chronic_disease
or 58 60 558 560 O
ischemia 61 69 561 569 B-chronic_disease

Eastern 0 7 570 577 B-clinical_variable
Cooperative 8 19 578 589 I-clinical_variable
Oncology 20 28 590 598 I-clinical_variable
Group 29 34 599 604 I-clinical_variable
( 35 36 605 606 I-clinical_variable
ECOG 36 40 606 610 I-clinical_variable
) 40 41 610 611 I-clinical_variable
performance 42 53 612 623 I-clinical_variable
status 54 60 624 630 I-clinical_variable
of 61 63 631 633 O
0 64 65 634 635 B-lower_bound
or 66 68 636 638 O
1 69 70 639 640 B-upper_bound

For 0 3 641 644 O
Parts 4 9 645 650 O
4 10 11 651 652 O
and 12 15 653 656 O
5 16 17 657 658 O
, 17 18 658 659 O
radiation 19 28 660 669 B-treatment
therapy 29 36 670 677 I-treatment
is 37 39 678 680 O
omitted 40 47 681 688 O

For 0 3 689 692 O
patients 4 12 693 701 O
enrolled 13 21 702 710 O
in 22 24 711 713 O
Part 25 29 714 718 O
2 30 31 719 720 O
or 32 34 721 723 O
Part 35 39 724 728 O
4 40 41 729 730 O
with 42 46 731 735 O
the 47 50 736 739 O
potential 51 60 740 749 O
to 61 63 750 752 O
receive 64 71 753 760 O
pembrolizumab 72 85 761 774 B-treatment

For 0 3 775 778 O
procedures 4 14 779 789 O
with 15 19 790 794 O
moderate 20 28 795 803 O
or 29 31 804 806 O
significant 32 43 807 818 O
risk 44 48 819 823 O
of 49 51 824 826 O
bleeding 52 60 827 835 B-chronic_disease
, 60 61 835 836 O
long 62 66 837 841 B-treatment
- 66 67 841 842 I-treatment
acting 67 73 842 848 I-treatment
agents 74 80 849 855 I-treatment
such 81 85 856 860 O
as 86 88 861 863 O
aspirin 89 96 864 871 B-treatment
or 97 99 872 874 O
clopidogrel 100 111 875 886 B-treatment
should 112 118 887 893 O
be 119 121 894 896 O
discussed 122 131 897 906 O
with 132 136 907 911 O
the 137 140 912 915 O
Medical 141 148 916 923 O
Monitor 149 156 924 931 O
and 157 160 932 935 O
may 161 164 936 939 O
need 165 169 940 944 O
to 170 172 945 947 O
be 173 175 948 950 O
discontinued 176 188 951 963 O
before 189 195 964 970 O
G100 196 200 971 975 B-treatment
therapy 201 208 976 983 I-treatment

Has 0 3 984 987 O
had 4 7 988 991 O
an 8 10 992 994 O
allogeneic 11 21 995 1005 B-treatment
tissue 22 28 1006 1012 I-treatment
/ 28 29 1012 1013 O
solid 29 34 1013 1018 B-treatment
organ 35 40 1019 1024 I-treatment
transplant 41 51 1025 1035 I-treatment

Has 0 3 1036 1039 O
received 4 12 1040 1048 O
prior 13 18 1049 1054 B-treatment
therapy 19 26 1055 1062 I-treatment
with 27 31 1063 1067 O
an 32 34 1068 1070 O
anti 35 39 1071 1075 B-treatment
- 39 40 1075 1076 I-treatment
PD-1 40 44 1076 1080 I-treatment
, 44 45 1080 1081 O
anti 46 50 1082 1086 B-treatment
- 50 51 1086 1087 I-treatment
programmed 51 61 1087 1097 I-treatment
death 62 67 1098 1103 I-treatment
ligand 68 74 1104 1110 I-treatment
( 75 76 1111 1112 I-treatment
PD 76 78 1112 1114 I-treatment
- 78 79 1114 1115 I-treatment
L)1 79 82 1115 1118 I-treatment
, 82 83 1118 1119 O
or 84 86 1120 1122 O
anti 87 91 1123 1127 B-treatment
- 91 92 1127 1128 I-treatment
PD 92 94 1128 1130 I-treatment
- 94 95 1130 1131 I-treatment
L2 95 97 1131 1133 I-treatment
agent 98 103 1134 1139 I-treatment

Has 0 3 1140 1143 O
undergone 4 13 1144 1153 O
prior 14 19 1154 1159 B-treatment
allogeneic 20 30 1160 1170 I-treatment
hematopoietic 31 44 1171 1184 I-treatment
stem 45 49 1185 1189 I-treatment
cell 50 54 1190 1194 I-treatment
transplantation 55 70 1195 1210 I-treatment
within 71 77 1211 1217 O
the 78 81 1218 1221 O
last 82 86 1222 1226 B-upper_bound
5 87 88 1227 1228 I-upper_bound
years 89 94 1229 1234 I-upper_bound

History 0 7 1235 1242 O
of 8 10 1243 1245 O
( 11 12 1246 1247 O
non 12 15 1247 1250 O
- 15 16 1250 1251 O
infectious 16 26 1251 1261 O
) 26 27 1261 1262 O
pneumonitis 28 39 1263 1274 B-chronic_disease
that 40 44 1275 1279 O
required 45 53 1280 1288 O
steroids 54 62 1289 1297 B-treatment
or 63 65 1298 1300 O
has 66 69 1301 1304 O
current 70 77 1305 1312 O
pneumonitis 78 89 1313 1324 O
or 90 92 1325 1327 O
interstitial 93 105 1328 1340 B-chronic_disease
lung 106 110 1341 1345 I-chronic_disease
disease 111 118 1346 1353 I-chronic_disease

History 0 7 1354 1361 O
of 8 10 1362 1364 O
other 11 16 1365 1370 O
cancer 17 23 1371 1377 B-cancer
within 24 30 1378 1384 O
2 31 32 1385 1386 B-upper_bound
years 33 38 1387 1392 I-upper_bound
( 39 40 1393 1394 O
except 40 46 1394 1400 O
non 47 50 1401 1404 B-cancer
- 50 51 1404 1405 I-cancer
melanoma 51 59 1405 1413 I-cancer
cutaneous 60 69 1414 1423 I-cancer
malignancies 70 82 1424 1436 I-cancer
and 83 86 1437 1440 O
cervical 87 95 1441 1449 B-cancer
carcinoma 96 105 1450 1459 I-cancer
in 106 108 1460 1462 I-cancer
situ 109 113 1463 1467 I-cancer
) 113 114 1467 1468 O

INR 0 3 1469 1472 B-clinical_variable
( 4 5 1473 1474 I-clinical_variable
prothrombin 5 16 1474 1485 I-clinical_variable
time 17 21 1486 1490 I-clinical_variable
ratio 22 27 1491 1496 I-clinical_variable
) 27 28 1496 1497 I-clinical_variable
or 29 31 1498 1500 O
partial 32 39 1501 1508 B-clinical_variable
thromboplastin 40 54 1509 1523 I-clinical_variable
time 55 59 1524 1528 I-clinical_variable
( 60 61 1529 1530 I-clinical_variable
PTT 61 64 1530 1533 I-clinical_variable
) 64 65 1533 1534 I-clinical_variable
> 66 67 1535 1536 O
1.5 67 70 1536 1539 B-lower_bound
x 71 72 1540 1541 I-lower_bound
ULN 73 76 1542 1545 I-lower_bound

In 0 2 1546 1548 O
Part 3 7 1549 1553 O
4 8 9 1554 1555 O
, 9 10 1555 1556 O
enrollment 11 21 1557 1567 O
is 22 24 1568 1570 O
limited 25 32 1571 1578 O
to 33 35 1579 1581 O
relapsed 36 44 1582 1590 O
or 45 47 1591 1593 O
refractory 48 58 1594 1604 O
follicular 59 69 1605 1615 B-cancer
NHL 70 73 1616 1619 I-cancer
patients 74 82 1620 1628 O

Investigational 0 15 1629 1644 B-treatment
therapy 16 23 1645 1652 I-treatment
within 24 30 1653 1659 O
4 31 32 1660 1661 B-upper_bound
weeks 33 38 1662 1667 I-upper_bound
prior 39 44 1668 1673 I-upper_bound
to 45 47 1674 1676 O
G100 48 52 1677 1681 B-treatment
dosing 53 59 1682 1688 O

Life 0 4 1689 1693 B-clinical_variable
expectancy 5 15 1694 1704 I-clinical_variable
of 16 18 1705 1707 O
≥ 19 20 1708 1709 O
6 21 22 1710 1711 B-lower_bound
months 23 29 1712 1718 I-lower_bound
per 30 33 1719 1722 O
the 34 37 1723 1726 O
investigator 38 50 1727 1739 O

Measurable 0 10 1740 1750 O
tumor 11 16 1751 1756 B-cancer
mass(es 17 24 1757 1764 O
) 24 25 1764 1765 O
accessible 26 36 1766 1776 O
for 37 40 1777 1780 O
intratumoral 41 53 1781 1793 B-treatment
injection 54 63 1794 1803 I-treatment
must 64 68 1804 1808 O
be 69 71 1809 1811 O
present 72 79 1812 1819 O
for 80 83 1820 1823 O
treatment 84 93 1824 1833 B-treatment
and 94 97 1834 1837 O
assessment 98 108 1838 1848 O
of 109 111 1849 1851 O
response 112 120 1852 1860 O

Myocardial 0 10 1861 1871 B-chronic_disease
infarction 11 21 1872 1882 I-chronic_disease
within 22 28 1883 1889 O
6 29 30 1890 1891 B-upper_bound
months 31 37 1892 1898 I-upper_bound
of 38 40 1899 1901 O
study 41 46 1902 1907 O
initiation 47 57 1908 1918 O
, 57 58 1918 1919 O
active 59 65 1920 1926 O
cardiac 66 73 1927 1934 B-chronic_disease
ischemia 74 82 1935 1943 I-chronic_disease
or 83 85 1944 1946 O
New 86 89 1947 1950 B-clinical_variable
York 90 94 1951 1955 I-clinical_variable
Heart 95 100 1956 1961 I-clinical_variable
Association 101 112 1962 1973 I-clinical_variable
( 113 114 1974 1975 I-clinical_variable
NYHA 114 118 1975 1979 I-clinical_variable
) 118 119 1979 1980 I-clinical_variable
Grade 120 125 1981 1986 B-lower_bound
III 126 129 1987 1990 I-lower_bound
or 130 132 1991 1993 O
IV 133 135 1994 1996 B-upper_bound
heart 136 141 1997 2002 B-chronic_disease
failure 142 149 2003 2010 I-chronic_disease

Other 0 5 2011 2016 O
immunosuppressive 6 23 2017 2034 B-treatment
medications 24 35 2035 2046 I-treatment
such 36 40 2047 2051 O
as 41 43 2052 2054 O
methotrexate 44 56 2055 2067 B-treatment
, 56 57 2067 2068 O
cyclosporine 58 70 2069 2081 B-treatment
, 70 71 2081 2082 O
azathioprine 72 84 2083 2095 B-treatment
or 85 87 2096 2098 O
conditions 88 98 2099 2109 O
such 99 103 2110 2114 O
as 104 106 2115 2117 O
common 107 113 2118 2124 O
variable 114 122 2125 2133 O
hypogammaglobulinemia 123 144 2134 2155 B-chronic_disease

Peripheral 0 10 2156 2166 B-clinical_variable
blood 11 16 2167 2172 I-clinical_variable
leukocyte 17 26 2173 2182 I-clinical_variable
count 27 32 2183 2188 I-clinical_variable
( 33 34 2189 2190 I-clinical_variable
WBC 34 37 2190 2193 I-clinical_variable
) 37 38 2193 2194 I-clinical_variable
< 39 40 2195 2196 O
3000 41 45 2197 2201 B-upper_bound
/ 45 46 2201 2202 I-upper_bound
mm3 46 49 2202 2205 I-upper_bound

Pregnant 0 8 2206 2214 B-pregnancy
or 9 11 2215 2217 O
nursing 12 19 2218 2225 O

Prior 0 5 2226 2231 B-treatment
administration 6 20 2232 2246 I-treatment
of 21 23 2247 2249 I-treatment
other 24 29 2250 2255 I-treatment
intratumoral 30 42 2256 2268 I-treatment
immunotherapeutics 43 61 2269 2287 I-treatment

Psychiatric 0 11 2288 2299 B-chronic_disease
, 11 12 2299 2300 O
other 13 18 2301 2306 O
medical 19 26 2307 2314 B-chronic_disease
illness 27 34 2315 2322 I-chronic_disease
or 35 37 2323 2325 O
other 38 43 2326 2331 O
condition 44 53 2332 2341 O
that 54 58 2342 2346 O
in 59 61 2347 2349 O
the 62 65 2350 2353 O
opinion 66 73 2354 2361 O
of 74 76 2362 2364 O
the 77 80 2365 2368 O
PI 81 83 2369 2371 O
prevents 84 92 2372 2380 O
compliance 93 103 2381 2391 O
with 104 108 2392 2396 O
study 109 114 2397 2402 O
procedures 115 125 2403 2413 O
or 126 128 2414 2416 O
ability 129 136 2417 2424 O
to 137 139 2425 2427 O
provide 140 147 2428 2435 O
valid 148 153 2436 2441 O
informed 154 162 2442 2450 O
consent 163 170 2451 2458 O

Received 0 8 2459 2467 O
a 9 10 2468 2469 O
live 11 15 2470 2474 B-treatment
virus 16 21 2475 2480 I-treatment
vaccine 22 29 2481 2488 I-treatment
within 30 36 2489 2495 O
30 37 39 2496 2498 B-upper_bound
days 40 44 2499 2503 I-upper_bound
of 45 47 2504 2506 O
planned 48 55 2507 2514 O
study 56 61 2515 2520 O
start 62 67 2521 2526 O

Recent 0 6 2527 2533 O
( 7 8 2534 2535 O
< 8 9 2535 2536 O
1 10 11 2537 2538 B-upper_bound
week 12 16 2539 2543 I-upper_bound
ago 17 20 2544 2547 O
) 20 21 2547 2548 O
clinically 22 32 2549 2559 O
significant 33 44 2560 2571 O
infection 45 54 2572 2581 B-chronic_disease
, 54 55 2581 2582 O
active 56 62 2583 2589 B-chronic_disease
tuberculosis 63 75 2590 2602 I-chronic_disease
or 76 78 2603 2605 O
evidence 79 87 2606 2614 O
of 88 90 2615 2617 O
active 91 97 2618 2624 O
hepatitis 98 107 2625 2634 B-chronic_disease
B 108 109 2635 2636 I-chronic_disease
, 109 110 2636 2637 O
hepatitis 111 120 2638 2647 B-chronic_disease
C 121 122 2648 2649 I-chronic_disease
or 123 125 2650 2652 O
HIV 126 129 2653 2656 B-chronic_disease
infection 130 139 2657 2666 I-chronic_disease

Significant 0 11 2667 2678 O
autoimmune 12 22 2679 2689 B-chronic_disease
disease 23 30 2690 2697 I-chronic_disease
, 30 31 2697 2698 O
including 32 41 2699 2708 O
active 42 48 2709 2715 O
non 49 52 2716 2719 O
- 52 53 2719 2720 O
infectious 53 63 2720 2730 O
pneumonitis 64 75 2731 2742 B-chronic_disease
, 75 76 2742 2743 O
with 77 81 2744 2748 O
the 82 85 2749 2752 O
exception 86 95 2753 2762 O
of 96 98 2763 2765 O
alopecia 99 107 2766 2774 B-chronic_disease
, 107 108 2774 2775 O
vitiligo 109 117 2776 2784 B-chronic_disease
, 117 118 2784 2785 O
hypothyroidism 119 133 2786 2800 B-chronic_disease
or 134 136 2801 2803 O
other 137 142 2804 2809 O
conditions 143 153 2810 2820 O
that 154 158 2821 2825 O
have 159 163 2826 2830 O
never 164 169 2831 2836 O
been 170 174 2837 2841 O
clinically 175 185 2842 2852 O
active 186 192 2853 2859 O
or 193 195 2860 2862 O
were 196 200 2863 2867 O
transient 201 210 2868 2877 O
and 211 214 2878 2881 O
have 215 219 2882 2886 O
completely 220 230 2887 2897 O
resolved 231 239 2898 2906 O
and 240 243 2907 2910 O
require 244 251 2911 2918 O
no 252 254 2919 2921 O
ongoing 255 262 2922 2929 O
therapy 263 270 2930 2937 B-treatment

Significant 0 11 2938 2949 O
immunosuppression 12 29 2950 2967 B-chronic_disease

Subjects 0 8 2968 2976 O
who 9 12 2977 2980 O
have 13 17 2981 2985 O
had 18 21 2986 2989 O
a 22 23 2990 2991 O
transplant 24 34 2992 3002 B-treatment
greater 35 42 3003 3010 O
than 43 47 3011 3015 O
5 48 49 3016 3017 B-lower_bound
years 50 55 3018 3023 I-lower_bound
ago 56 59 3024 3027 O
are 60 63 3028 3031 O
eligible 64 72 3032 3040 O
as 73 75 3041 3043 O
long 76 80 3044 3048 O
as 81 83 3049 3051 O
there 84 89 3052 3057 O
are 90 93 3058 3061 O
no 94 96 3062 3064 O
symptoms 97 105 3065 3073 O
of 106 108 3074 3076 O
GVHD 109 113 3077 3081 B-chronic_disease

Use 0 3 3082 3085 O
of 4 6 3086 3088 O
anti 7 11 3089 3093 B-treatment
- 11 12 3093 3094 I-treatment
coagulant 12 21 3094 3103 I-treatment
agents 22 28 3104 3110 I-treatment
or 29 31 3111 3113 O
history 32 39 3114 3121 O
a 40 41 3122 3123 O
significant 42 53 3124 3135 O
bleeding 54 62 3136 3144 B-chronic_disease
diathesis 63 72 3145 3154 I-chronic_disease

absolute 0 8 3155 3163 B-clinical_variable
neutrophil 9 19 3164 3174 I-clinical_variable
count 20 25 3175 3180 I-clinical_variable
≤ 26 27 3181 3182 O
1500 28 32 3183 3187 B-upper_bound
/ 32 33 3187 3188 I-upper_bound
mm3 33 36 3188 3191 I-upper_bound

alanine 0 7 3192 3199 B-clinical_variable
aminotransferase 8 24 3200 3216 I-clinical_variable
( 25 26 3217 3218 I-clinical_variable
ALT 26 29 3218 3221 I-clinical_variable
) 29 30 3221 3222 I-clinical_variable
, 30 31 3222 3223 O
and 32 35 3224 3227 O
aspartate 36 45 3228 3237 B-clinical_variable
aminotransferase 46 62 3238 3254 I-clinical_variable
( 63 64 3255 3256 I-clinical_variable
AST 64 67 3256 3259 I-clinical_variable
) 67 68 3259 3260 I-clinical_variable
> 69 70 3261 3262 O
2.5 71 74 3263 3266 B-lower_bound
x 75 76 3267 3268 I-lower_bound
Upper 77 82 3269 3274 I-lower_bound
Limit 83 88 3275 3280 I-lower_bound
of 89 91 3281 3283 I-lower_bound
Normal 92 98 3284 3290 I-lower_bound
( 99 100 3291 3292 I-lower_bound
ULN 100 103 3292 3295 I-lower_bound
) 103 104 3295 3296 I-lower_bound

hemoglobin 0 10 3297 3307 B-clinical_variable
< 11 12 3308 3309 O
10 13 15 3310 3312 B-upper_bound
gm 16 18 3313 3315 I-upper_bound
/ 18 19 3315 3316 I-upper_bound
dL 19 21 3316 3318 I-upper_bound

platelets 0 9 3319 3328 B-clinical_variable
< 10 11 3329 3330 O
75000 12 17 3331 3336 B-upper_bound
/ 17 18 3336 3337 I-upper_bound
mm3 18 21 3337 3340 I-upper_bound

total 0 5 3341 3346 B-clinical_variable
serum 6 11 3347 3352 I-clinical_variable
bilirubin 12 21 3353 3362 I-clinical_variable
> 22 23 3363 3364 O
1.5 24 27 3365 3368 B-lower_bound
x 28 29 3369 3370 I-lower_bound
ULN 30 33 3371 3374 I-lower_bound
( 34 35 3375 3376 O
patients 35 43 3376 3384 O
with 44 48 3385 3389 O
Gilbert 49 56 3390 3397 B-chronic_disease
's 56 58 3397 3399 I-chronic_disease
Disease 59 66 3400 3407 I-chronic_disease
may 67 70 3408 3411 O
be 71 73 3412 3414 O
included 74 82 3415 3423 O
if 83 85 3424 3426 O
their 86 91 3427 3432 O
total 92 97 3433 3438 B-clinical_variable
bilirubin 98 107 3439 3448 I-clinical_variable
is 108 110 3449 3451 O
≤3.0 111 115 3452 3456 O
mg 116 118 3457 3459 I-upper_bound
/ 118 119 3459 3460 I-upper_bound
dL 119 121 3460 3462 I-upper_bound
) 121 122 3462 3463 O

≥ 0 1 3464 3465 O
18 2 4 3466 3468 B-lower_bound
years 5 10 3469 3474 I-lower_bound
of 11 13 3475 3477 O
age 14 17 3478 3481 B-age

